Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports
Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.